MedPath

上海峰林生物科技有限公司

Ownership
-
Established
2015-08-18
Employees
-
Market Cap
-
Website
http://www.maplebio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Hemofiltration Replacement Fluid of Sodium Citrate

Product Name
枸橼酸钠血滤置换液
Approval Number
国药准字H20253005
Approval Date
Jan 2, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.